• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国际浆膜腔液细胞病理学报告系统在胸腔积液常规报告中的应用及恶性肿瘤风险评估。

Application of the International System for Reporting Serous Fluid Cytopathology in routine reporting of pleural effusion and assessment of the risk of malignancy.

机构信息

Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bhubaneswar, India.

出版信息

Diagn Cytopathol. 2021 Oct;49(10):1089-1098. doi: 10.1002/dc.24837. Epub 2021 Jul 21.

DOI:10.1002/dc.24837
PMID:34289263
Abstract

INTRODUCTION

The International System for Reporting Serous Fluid Cytopathology (ISRSFC) was proposed by the International Academy of Cytology and the American Society of Cytopathology.

AIM OF THE STUDY

We have applied this system for reporting of pleural effusion cytology and report our experience.

MATERIALS AND METHODS

All the pleural effusions from January 2019 to June 2020 were retrieved from the database. All these cases were reviewed and recategorized according to the proposed system of 5 categories: non-diagnostic (ND), negative for malignancy (NFM), atypia of uncertain significance (AUS), suspicious for malignancy (SFM), and malignant (MAL). The risk of malignancy (ROM) for each category was evaluated.

RESULTS

A total of 939 cases were studied. The age of patients ranged from 2 to 88 years, and the volume of fluid ranged from 1 to 600 ml. There were 41 ND (4.37%), 697 NFM (74.23%), 44 AUS (4.69%), 27 SFM (2.88%), and 130 MAL (13.84%) cases. The ROM for the categories were found to be 87.5%, 51.61%, 88.23%, 87.5%, and 100% respectively.

CONCLUSIONS

The ISRSFC is a user-friendly system for use in reporting of pleural fluid. The criteria for defining the various categories need to be further elaborative and stricter for this system to be more effective. More studies are required for the estimation of the ROM for each category.

摘要

简介

国际浆膜腔液细胞病理学报告系统(ISRSFC)由国际细胞学学会和美国细胞病理学学会提出。

目的

我们应用该系统报告胸腔积液细胞学,并报告我们的经验。

材料和方法

从 2019 年 1 月至 2020 年 6 月,从数据库中检索所有胸腔积液。根据提出的 5 类系统,对所有这些病例进行了回顾和重新分类:非诊断性(ND)、无恶性肿瘤(NFM)、非典型意义不确定(AUS)、疑似恶性肿瘤(SFM)和恶性肿瘤(MAL)。评估每个类别的恶性肿瘤风险(ROM)。

结果

共研究了 939 例。患者年龄 2-88 岁,胸腔积液量 1-600ml。41 例 ND(4.37%)、697 例 NFM(74.23%)、44 例 AUS(4.69%)、27 例 SFM(2.88%)和 130 例 MAL(13.84%)。发现各分类的 ROM 分别为 87.5%、51.61%、88.23%、87.5%和 100%。

结论

ISRSFC 是一种用户友好的胸腔液报告系统。需要进一步详细说明和严格定义各分类的标准,以使该系统更加有效。需要进一步研究以评估每个类别的 ROM。

相似文献

1
Application of the International System for Reporting Serous Fluid Cytopathology in routine reporting of pleural effusion and assessment of the risk of malignancy.国际浆膜腔液细胞病理学报告系统在胸腔积液常规报告中的应用及恶性肿瘤风险评估。
Diagn Cytopathol. 2021 Oct;49(10):1089-1098. doi: 10.1002/dc.24837. Epub 2021 Jul 21.
2
A Retrospective Analysis of the Application of the Newly Proposed International System for Reporting Serous Fluid Cytopathology on Serous Effusion Specimens: An Institutional Experience.回顾性分析新提出的国际浆膜腔液细胞病理学报告系统在浆膜腔积液标本中的应用:机构经验。
Acta Cytol. 2023;67(1):70-79. doi: 10.1159/000527398. Epub 2022 Dec 7.
3
Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) on Reporting Pericardial Effusion Cytology.国际浆膜液细胞病理学报告系统(ISRSFC)在心包积液细胞学报告中的应用。
Acta Cytol. 2020;64(5):477-485. doi: 10.1159/000507311. Epub 2020 May 18.
4
Categorisation of serous effusions using the International System for Reporting Serous Fluid Cytopathology and assessment of risk of malignancy with diagnostic accuracy.使用国际浆膜腔液细胞病理学报告系统对浆膜腔积液进行分类,并评估诊断准确性的恶性肿瘤风险。
Cytopathology. 2022 Mar;33(2):176-184. doi: 10.1111/cyt.13089. Epub 2021 Dec 28.
5
Application of international system for reporting serous fluid cytology (ISRSFC) in effusion samples-a prospective study in an oncology setting.国际浆膜腔液细胞学报告系统(ISRSFC)在积液标本中的应用——一项肿瘤学环境中的前瞻性研究。
J Am Soc Cytopathol. 2023 Sep-Oct;12(5):351-361. doi: 10.1016/j.jasc.2023.04.005. Epub 2023 May 3.
6
Risk of malignancy assessment of the International System for Reporting Serous Fluid Cytopathology: Experience in a community hospital setting and comparison with other studies.国际浆液性液体细胞病理学报告系统的恶性肿瘤风险评估:社区医院环境中的经验及与其他研究的比较。
Cancer Cytopathol. 2022 Dec;130(12):964-973. doi: 10.1002/cncy.22638. Epub 2022 Aug 22.
7
Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.浆膜腔积液的细胞组织学相关性应用新提出的国际浆膜腔液细胞病理学报告系统:肿瘤中心的经验。
Diagn Cytopathol. 2021 May;49(5):596-605. doi: 10.1002/dc.24440. Epub 2020 Apr 27.
8
Comprehensive evaluation of benign and malignant etiologies of different serous effusions with the International System for Reporting Serous Fluid Cytopathology: A multi-institutional study in Taiwan.国际浆膜腔液细胞病理学报告系统对不同浆膜腔积液良恶性病因的综合评估:台湾的一项多机构研究。
Cancer Cytopathol. 2024 Mar;132(3):169-178. doi: 10.1002/cncy.22783. Epub 2023 Dec 8.
9
Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) in reporting serous effusion: A retrospective study.国际浆膜腔液细胞病理报告系统(ISRSFC)在浆膜腔积液报告中的应用:一项回顾性研究。
Medicine (Baltimore). 2023 Oct 27;102(43):e35707. doi: 10.1097/MD.0000000000035707.
10
Application of the International System for Reporting Serous Fluid Cytopathology to pericardial fluid: Root cause analysis of indeterminate diagnoses, cytohistological correlation, and assessment of malignancy risk.国际浆膜腔液细胞病理学报告系统在心包液中的应用:不明确诊断的根本原因分析、细胞组织学相关性及恶性风险评估。
Cancer Cytopathol. 2023 Jul;131(7):433-441. doi: 10.1002/cncy.22696. Epub 2023 Mar 27.

引用本文的文献

1
The International System for Reporting Serous Fluid Cytopathology-An Updated Review.国际浆液性液体细胞病理学报告系统——最新综述
J Clin Transl Pathol. 2023;3(4):160-177. doi: 10.14218/jctp.2023.00025. Epub 2023 Dec 20.
2
Deciphering Serous Effusions Using the New International System for Reporting Serous Fluid Cytopathology.使用新的国际浆液性液体细胞病理学报告系统解读浆液性积液
Cureus. 2024 May 10;16(5):e60042. doi: 10.7759/cureus.60042. eCollection 2024 May.
3
The Role of Novel Tiered Reporting System in Serous Fluid Cytology and Risk of Malignancy Assessment: A Retrospective Study in a Tertiary Care Center.
新型分层报告系统在浆液性液体细胞学及恶性风险评估中的作用:一项三级医疗中心的回顾性研究
J Cytol. 2023 Jul-Sep;40(3):107-113. doi: 10.4103/joc.joc_107_22. Epub 2023 Aug 14.
4
A retrospective analysis of serous effusions based on the newly proposed international system for reporting serous fluid cytopathology: a report of 3633 cases in an oncological center.基于新提出的国际浆膜腔液细胞学报告系统的浆膜腔积液回顾性分析:肿瘤中心 3633 例病例报告。
Diagn Pathol. 2022 Jul 2;17(1):56. doi: 10.1186/s13000-022-01241-4.
5
Combination of Biochemical and Cytological Findings for Better Diagnosis in Pleural Effusions.联合生化和细胞学检查结果以提高胸腔积液的诊断水平。
Adv Exp Med Biol. 2022;1374:51-62. doi: 10.1007/5584_2021_703.
6
Application of the International System for Reporting Serous Fluid Cytopathology with Cytohistological Correlation and Risk of Malignancy Assessment.国际浆液性液体细胞病理学报告系统在细胞组织学相关性及恶性风险评估中的应用
Diagnostics (Basel). 2021 Nov 28;11(12):2223. doi: 10.3390/diagnostics11122223.